ABBOTT LABORATORIES Operating Lease, Payments
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-02-20
- ABBOTT LABORATORIES operating lease, payments for the quarter ending 2019-12-31 was $63.00M.
- ABBOTT LABORATORIES operating lease, payments for the quarter ending 2019-09-30 was $64.00M.
- ABBOTT LABORATORIES operating lease, payments for the quarter ending 2019-06-30 was $63.00M.
- ABBOTT LABORATORIES operating lease, payments for the quarter ending 2019-03-31 was $63.00M.
- ABBOTT LABORATORIES operating lease, payments for fiscal 2025 was $315.00M, a 5.00% increase from fiscal 2024.
- ABBOTT LABORATORIES operating lease, payments for fiscal 2024 was $300.00M, a 8.70% increase from fiscal 2023.
- ABBOTT LABORATORIES operating lease, payments for fiscal 2023 was $276.00M, a 0.73% increase from fiscal 2022.
- ABBOTT LABORATORIES operating lease, payments for fiscal 2022 was $274.00M, a 4.53% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $315.00M 10-K · filed 2026-02-20 | |||
| 2024-12-31 | $300.00M 10-K · filed 2026-02-20 | |||
| 2023-12-31 | $276.00M 10-K · filed 2026-02-20 | |||
| 2022-12-31 | $274.00M 10-K · filed 2025-02-21 | |||
| 2021-12-31 | $287.00M 10-K · filed 2024-02-16 | |||
| 2020-12-31 | $264.00M 10-K · filed 2023-02-17 | |||
| 2019-12-31 | $63.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $127.00M derived: sum of 2 quarters · filed 2022-02-18 | $190.00M derived: sum of 3 quarters · filed 2022-02-18 | $253.00M 10-K · filed 2022-02-18 |
| 2019-09-30 | $64.00M 10-Q · filed 2019-10-31 | $127.00M derived: sum of 2 quarters · filed 2019-10-31 | $190.00M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $63.00M 10-Q · filed 2019-07-31 | $126.00M 10-Q · filed 2019-07-31 | ||
| 2019-03-31 | $63.00M 10-Q · filed 2019-05-01 |